415 related articles for article (PubMed ID: 17658665)
21. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
Chen PC; Lao CL; Chen JC
J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
[TBL] [Abstract][Full Text] [Related]
22. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
[TBL] [Abstract][Full Text] [Related]
23. [Altered behavioral response to centrally acting drugs in mice lacking PACAP].
Shintani N; Tanaka K; Hashimoto H; Baba A
Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():1P-4P. PubMed ID: 14727506
[TBL] [Abstract][Full Text] [Related]
24. Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus.
Lee KW; Kim HC; Lee SY; Jang CG
Neuroscience; 2011 Mar; 178():101-7. PubMed ID: 21256196
[TBL] [Abstract][Full Text] [Related]
25. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
Steed E; Jones CA; McCreary AC
Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
[TBL] [Abstract][Full Text] [Related]
26. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V
J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
[TBL] [Abstract][Full Text] [Related]
27. Methamphetamine and brain histamine: a study using histamine-related gene knockout mice.
Iwabuchi K; Kubota Y; Ito C; Watanabe T; Watanabe T; Yanai K
Ann N Y Acad Sci; 2004 Oct; 1025():129-34. PubMed ID: 15542709
[TBL] [Abstract][Full Text] [Related]
28. Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice.
Ishihama T; Ago Y; Shintani N; Hashimoto H; Baba A; Takuma K; Matsuda T
Behav Brain Res; 2010 Jun; 209(2):274-80. PubMed ID: 20144662
[TBL] [Abstract][Full Text] [Related]
29. Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice.
Shin EJ; Bing G; Chae JS; Kim TW; Bach JH; Park DH; Yamada K; Nabeshima T; Kim HC
J Neurosci Res; 2009 Dec; 87(16):3679-86. PubMed ID: 19598248
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
[TBL] [Abstract][Full Text] [Related]
31. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
Yoo JH; Nam YS; Lee SY; Jang CG
Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
[TBL] [Abstract][Full Text] [Related]
33. Effect of methamphetamine on cognition and repetitive motor behavior of mice deficient for dopamine D2 and D3 receptors.
Glickstein SB; Schmauss C
Ann N Y Acad Sci; 2004 Oct; 1025():110-8. PubMed ID: 15542707
[TBL] [Abstract][Full Text] [Related]
34. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
[TBL] [Abstract][Full Text] [Related]
35. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
[TBL] [Abstract][Full Text] [Related]
36. Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonist in mice.
Nakamura S; Ago Y; Hayashi A; Itoh S; Kakuda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2006 Dec; 60(7):479-84. PubMed ID: 16952156
[TBL] [Abstract][Full Text] [Related]
37. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice.
Karper PE; De la Rosa H; Newman ER; Krall CM; Nazarian A; McDougall SA; Crawford CA
Psychopharmacology (Berl); 2002 Feb; 159(4):407-14. PubMed ID: 11823893
[TBL] [Abstract][Full Text] [Related]
38. Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice.
He Z; Yan L; Yong Z; Dong Z; Dong H; Gong Z
Behav Brain Res; 2013 Feb; 239():172-6. PubMed ID: 23159705
[TBL] [Abstract][Full Text] [Related]
39. Effect of prenatal methadone on reinstated behavioral sensitization induced by methamphetamine in adolescent rats.
Wong CS; Lee YJ; Chiang YC; Fan LW; Ho IK; Tien LT
Behav Brain Res; 2014 Jan; 258():160-5. PubMed ID: 24157336
[TBL] [Abstract][Full Text] [Related]
40. Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation.
Suzuki T; Shindo K; Miyatake M; Kurokawa K; Higashiyama K; Suzuki M; Narita M
Eur J Pharmacol; 2007 Nov; 574(1):39-48. PubMed ID: 17869241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
